Infusion Pumps and Accessories Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Infusion Pump and Accessories/Disposables), By Application (Gastroenterology, Diabetes Management, Hematology, and Other Applications), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region and Competition, 2020-2030F

Market Overview

The Global Infusion Pumps and Accessories Market, valued at USD 18.09 Billion in 2024, is projected to experience a CAGR of 8.10% to reach USD 28.87 Billion by 2030. Infusion pumps are essential medical devices that precisely deliver fluids, medications, and nutrients into a patient's body, complemented by accessories such as IV sets and tubing. The market's growth is primarily supported by the increasing global prevalence of chronic diseases, including cancer and diabetes, which necessitate controlled long-term drug administration. Furthermore, the expanding geriatric population, frequently requiring extensive medication regimens, significantly contributes to market expansion. The rising demand for home healthcare solutions also drives adoption.

According to the American Cancer Society, in 2023, approximately 1.93 million new cancer cases were expected in the United States, underscoring the demand for specialized oncology infusion solutions. A significant challenge impeding market expansion, however, is the substantial upfront cost associated with advanced infusion pump systems, alongside ongoing maintenance and training requirements.

Key Market Drivers

The increasing prevalence of chronic diseases significantly drives the demand for Global Infusion Pumps and Accessories. Conditions such as diabetes, autoimmune disorders, and various cancers necessitate long-term, precise, and often continuous administration of medications, nutrients, and fluids, making infusion therapy indispensable. This growing patient demographic requires advanced systems capable of delivering complex therapeutic regimens outside traditional hospital settings. According to the World Health Organization (WHO) and the NCD Risk Factor Collaboration (NCD-RisC), in November 2024, over 800 million adults worldwide were living with diabetes, marking a quadrupling since 1990. This substantial and rising patient population underscores the critical need for reliable infusion solutions and their supporting accessories.

Simultaneously, advancements in infusion pump technology represent another pivotal driver. Ongoing innovation focuses on enhancing device precision, integrating smart features, improving connectivity for real-time monitoring, and developing more intuitive user interfaces. These technological strides aim to bolster patient safety by minimizing medication errors and optimizing therapeutic outcomes, while also improving clinical workflow efficiency. According to ICU Medical, in April 2025, their newly introduced Plum Solo and Plum Duo precision IV pumps are designed to deliver ±3% accuracy in real-world conditions, addressing delivery variability and enhancing patient care. Such developments expand the utility and adoption of infusion pumps across diverse healthcare environments. This dynamic innovation within the segment contributes to the broader medical technology sector, which itself demonstrates considerable value; according to MedTech Europe, the European medical technology market was estimated at roughly €170 billion in 2024.

Download Free Sample Report

Key Market Challenges

The substantial upfront cost associated with advanced infusion pump systems presents a significant challenge to the growth of the Global Infusion Pumps and Accessories Market. Healthcare providers, particularly hospitals and smaller clinics, operate within considerable budgetary constraints when evaluating the acquisition of new, high-technology medical equipment. This financial barrier directly limits the widespread adoption of modern infusion technologies, especially impacting facilities in regions with restricted healthcare budgets.

The allocation of funds within healthcare institutions frequently places pressure on capital equipment budgets. For instance, according to the American Hospital Association, in its report "Cost of Caring: Challenges Facing America's Hospitals in 2025," labor constituted 56% of total operating costs. Such significant operational expenses directly impact the funds available for substantial capital investments like advanced infusion pump systems. Consequently, institutions may defer necessary technology upgrades or opt for less expensive, potentially older models, thereby slowing the market penetration of innovative solutions. This reluctance to invest in costly new systems directly curtails market expansion by reducing purchase volumes and extending replacement cycles for existing equipment.

Key Market Trends

The expansion of home infusion therapy and outpatient care represents a significant shift in healthcare delivery, moving complex medical treatments from traditional institutional settings to more convenient and cost-effective environments. This trend is driven by an aging population, the rising prevalence of chronic conditions requiring long-term treatment, and a growing preference for care closer to home. The National Home Infusion Association (NHIA) reported a 5-8% increase in home infusion service claims for 2023, underscoring the growing utilization of these services. This shift demands infusion solutions that are portable, user-friendly, and capable of operating safely outside acute care settings. In a notable development, Rockfield Medical Devices received the NHIA 2025 Innovation Award for its Mobility+ enteral feeding system, an elastomeric, lightweight, and wearable device designed for home use, highlighting the industry's focus on innovative solutions for this expanding care model.

Another pivotal trend is the increasing integration of smart infusion systems with Electronic Medical Records (EMR). This integration enhances patient safety and streamlines clinical workflows by facilitating automated programming and documentation, thereby reducing manual data entry errors. ECRI, in its "2024-2025 Targeted Medication Safety Best Practices for Hospitals" published in February 2024, specifically recommends implementing bi-directional smart infusion pump interoperability with the electronic health record, along with establishing organizational expectations for auto-programming and documentation for all medication and hydration infusions. This interoperability allows for seamless communication between the pump and the EMR. For instance, Baxter International Inc. announced U. S. FDA 510(k) clearance of its Novum IQ large volume infusion pump with Dose IQ Safety Software in April 2024, which aims to automate the programming of infusion parameters and documentation when integrated with an EMR system to reduce potential programming errors.

Segmental Insights

The Hospitals & Clinics segment currently holds the largest share of the global infusion pumps and accessories market, driven by a high volume of patient admissions requiring precise and continuous medication delivery. This significant growth is primarily fueled by the increasing prevalence of chronic diseases such as cancer and diabetes, which necessitate advanced therapeutic interventions and long-term drug administration in controlled environments. Furthermore, the rising number of complex surgical procedures and the demand for enhanced patient safety solutions, including smart infusion systems, bolster the adoption of these devices in hospital and clinic settings. The presence of skilled healthcare professionals and substantial purchasing power within these facilities also contributes significantly to their sustained demand for sophisticated infusion technologies.

Regional Insights

North America leads the global infusion pumps and accessories market due to its advanced healthcare infrastructure and significant healthcare spending, which fosters the widespread adoption of innovative medical technologies, including smart infusion pumps. The region benefits from a high prevalence of chronic diseases requiring precise medication delivery and robust reimbursement policies that support the use of these devices. Furthermore, the strong presence of major market players and stringent regulatory oversight by bodies such as the U. S. Food and Drug Administration (FDA) drive continuous product development and ensure high standards of patient safety and quality.

Recent Developments

• In June 2025, PharmaSens and SiBionics announced a strategic collaboration focused on developing the next-generation Niia Signature insulin patch pump. This innovative project is set to create an all-in-one wearable device that seamlessly integrates insulin delivery technology from PharmaSens with continuous glucose sensing capabilities from SiBionics. The aim is to produce a single, compact automated patch pump system. This combined pump and continuous glucose monitor (CGM) represents a new product offering designed to provide a more integrated and user-friendly solution within the diabetes management segment of the Global Infusion Pumps and Accessories Market.

• In April 2025, ICU Medical Inc. introduced new precision IV pumps following 510(k) regulatory clearances from the U.S. Food and Drug Administration (FDA). These clearances pertained to the Plum Solo precision IV pump, a single-channel device designed to complement the existing dual-channel Plum Duo, and updated versions of the Plum Duo pump and LifeShield infusion safety software. This launch completed the initial phase of the company's IV Performance Platform, establishing a new category of precision IV pumps. These devices aim to mitigate delivery variability and ensure high data accuracy in infusion therapy, providing predictable performance for clinicians.

• In May 2024, Arecor Therapeutics plc announced a research collaboration with Medtronic. This partnership aims to develop a novel, high-concentration, and thermostable insulin formulation specifically for integration into a next-generation implantable infusion pump. The collaboration seeks to significantly advance insulin treatment by providing a product that could reduce the frequency of pump maintenance requirements, thereby enhancing patient care. This development is expected to broaden the clinical applications of implantable pumps for medical professionals and offer substantial healthcare cost efficiencies within the Global Infusion Pumps and Accessories Market.

• In April 2024, Baxter International Inc. announced that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software. This significant product launch expanded the Novum IQ Infusion Platform, which integrates Baxter's syringe infusion pump, enabling healthcare providers to utilize a cohesive system across diverse patient care environments. The platform is designed to streamline clinical workflows and minimize operational complexities for staff. The Novum IQ LVP supports the precise administration of high-volume infusions, contributing to enhanced patient safety and efficiency through its advanced connected solutions.

Key Market Players

• Baxter International Inc.
• Becton, Dickinson, and Company
• Braun Melsungen AG
• Terumo Corporation
• Eli Lilly and Company
• Pfizer Inc.
• ICU Medical Inc.
• Johnson & Johnson
• Nipro Corporation
• Option Care Health Inc.

Report Scope:

In this report, the Global Infusion Pumps and Accessories Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Infusion Pumps and Accessories Market, By Product Type:

o   Infusion Pump

o   Accessories/Disposables

• Infusion Pumps and Accessories Market, By Application:

o   Gastroenterology

o   Diabetes Management

o   Hematology

o   Other Applications

• Infusion Pumps and Accessories Market, By End User:

o   Hospitals & Clinics

o   Ambulatory Care Centers

o   Others

• Infusion Pumps and Accessories Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Infusion Pumps and Accessories Market.

Available Customizations:

Global Infusion Pumps and Accessories Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Infusion Pumps and Accessories Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]